Germline CDKN2A mutations in childhood melanoma.

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet (2006) 2.17

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet (2001) 1.67

Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30

Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence. Prog Biophys Mol Biol (2011) 0.88

Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. BMC Med Genet (2008) 0.84

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma. Br J Cancer (2004) 0.81

Familial malignant melanoma - overview. Hered Cancer Clin Pract (2004) 0.79

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom. Hered Cancer Clin Pract (2014) 0.78

High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families. Croat Med J (2006) 0.76

STUDIES IN IRON TRANSPORTATION AND METABOLISM. IV. OBSERVATIONS ON THE ABSORPTION OF IRON FROM THE GASTRO-INTESTINAL TRACT. J Clin Invest (1939) 10.38

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet (2000) 4.74

STUDIES IN IRON TRANSPORTATION AND METABOLISM. III. THE NORMAL FLUCTUATIONS OF SERUM AND "EASILY SPLIT-OFF" BLOOD IRON IN INDIVIDUAL SUBJECTS. J Clin Invest (1939) 3.29

Primary structure and transcription of an amplified genetic locus: the CUP1 locus of yeast. Proc Natl Acad Sci U S A (1984) 3.28

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut (2007) 2.28

Does uptake of antenatal HIV testing depend on the individual midwife? Cross sectional study. BMJ (1998) 2.27

The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol (2012) 2.24

Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control (2001) 2.21

A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet (1999) 2.15

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer (2005) 2.13

Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci. Am J Hum Genet (1992) 2.12

Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust (1995) 2.10

Hepatitis A outbreaks among illicit drug users and their contacts in Queensland, 1997. Med J Aust (1999) 2.05

The occupational overuse syndrome. N Z Med J (1994) 2.03

Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci (1996) 1.99

New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99

Measurements and simulations of ultralow emittance and ultrashort electron beams in the linac coherent light source. Phys Rev Lett (2009) 1.96

Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol (2001) 1.90

A Taq I polymorphism for the human transforming growth factor alpha gene (TGFA). Nucleic Acids Res (1987) 1.88

Infants' ability to use object kind information for object individuation. Cognition (1999) 1.80

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J (2010) 1.74

Genome scan of schizophrenia. Am J Psychiatry (1998) 1.74

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res (2000) 1.72

Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol (2001) 1.69

Aid to diagnosis of melanoma in primary medical care. BMJ (1995) 1.68

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet (2001) 1.67

Dairy consumption and patterns of mortality of Australian adults. Eur J Clin Nutr (2010) 1.61

CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst (1999) 1.59

Getting the guidance right: optimizing the quality of the UK national guidelines on sexually transmitted infections and closely related conditions. Int J STD AIDS (2004) 1.57

Leptin and the risk of Barrett's oesophagus. Gut (2008) 1.54

Genetic and environmental contributions to size, color, shape, and other characteristics of melanocytic naevi in a sample of adolescent twins. Genet Epidemiol (1999) 1.51

Increases in invasive melanoma in England, 1979-2006, by anatomical site. Br J Dermatol (2011) 1.50

Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst (1992) 1.47

Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism Relat Disord (2006) 1.46

The CDKN2A (p16) gene and human cancer. Mol Med (1997) 1.46

Specifications for the development of guidelines on the management of sexually transmitted infections and closely related conditions. Int J STD AIDS (2004) 1.45

Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. Eur Respir J (2007) 1.43

Epidemiology of solar keratoses. Br J Dermatol (1994) 1.42

Computerised information retrieval services in a teaching hospital. Br Med J (1980) 1.41

Contraception and medical gynaecology for HIV-positive women in a one-stop clinic. Int J STD AIDS (2008) 1.41

Medications prescribed for children. N Z Med J (1993) 1.40

A pilot trial of mobile, patient-performed teledermoscopy. Br J Dermatol (2015) 1.39

The CUP2 gene product, regulator of yeast metallothionein expression, is a copper-activated DNA-binding protein. Mol Cell Biol (1989) 1.38

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer (2008) 1.38

Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol (1996) 1.36

Asymmetries in ON and OFF visual pathways of humans revealed using contrast-evoked cortical potentials. Vis Neurosci (1988) 1.34

Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res (1997) 1.33

The Queensland Familial Melanoma Project: study design and characteristics of participants. Melanoma Res (1996) 1.31

The contribution of the DFNB1 locus to neurosensory deafness in a Caucasian population. Am J Hum Genet (1995) 1.30

Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer (2010) 1.29

Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology (1994) 1.28

Family planning in genitourinary medicine: an opportunistic service? Genitourin Med (1995) 1.25

Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? Br J Cancer (1995) 1.25

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer (1996) 1.25

Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res (1994) 1.24

Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry (1994) 1.24

Antenatal screening for syphilis. Still important in preventing disease. BMJ (1998) 1.23

p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer (1998) 1.22

Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol (1998) 1.21

Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet (1995) 1.18

Instant electronic imaging systems are superior to Polaroid at detecting sight-threatening diabetic retinopathy. Diabet Med (1998) 1.17

Willingness of homosexual and bisexual men in London to be screened for human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.16

The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol (1998) 1.16

A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol (2009) 1.12

Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res (1996) 1.10

Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res (1995) 1.10

Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer (1997) 1.10

Synchronous mating in yeasts. Methods Cell Biol (1975) 1.10

Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics. Sex Transm Infect (2004) 1.10

News from the frontline: sexually transmitted infections in teenagers attending a genitourinary clinic in south east London. Sex Transm Infect (2002) 1.09

Routine antenatal HIV testing. Is acceptable to women. BMJ (1999) 1.08

The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology (1998) 1.08

An epidemiological study of facial clefting in Manitoba. J Med Genet (1980) 1.07

CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res (1997) 1.07

Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control (2001) 1.07

Routine testing for HIV at infertility clinics. BMJ (1991) 1.06

Reliability of computer image analysis of pigmented skin lesions of Australian adolescents. Cancer (1996) 1.06

Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol (2012) 1.05

Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120. Virology (1995) 1.04

Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants? Gut (2010) 1.04

Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry (2005) 1.04

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04

Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res (2001) 1.03

Global predictions and tests of erythroid regulatory regions. Cold Spring Harb Symp Quant Biol (2003) 1.02

Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer. Am J Epidemiol (2001) 1.01

Acute pancreatitis in patients with fulminant hepatic failure. Gut (1973) 1.01

N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice. Neuroreport (2000) 1.01

Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer (1991) 1.00

Targeted therapies in the treatment of advanced/metastatic NSCLC. Eur J Cancer (2009) 0.99